VMP 41790511000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Leflunomide 10mg tablets
BNF code 1001030L0AAAAAA
Virtual Therapeutic Moiety Leflunomide
Date identifier became valid 12 May 2023
Previous product identifier 330057007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Leflunomide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Arava 10mg tablets (CST Pharma Ltd)
Arava 10mg tablets (Sanofi)
Arava 10mg tablets (Sigma Pharmaceuticals Plc)
Leflunomide 10mg tablets (A A H Pharmaceuticals Ltd)
Leflunomide 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Leflunomide 10mg tablets (Aspire Pharma Ltd)
Leflunomide 10mg tablets (Medihealth (Northern) Ltd)
Leflunomide 10mg tablets (Relonchem Ltd)
Leflunomide 10mg tablets (Rivopharm (UK) Ltd)
Leflunomide 10mg tablets (Sandoz Ltd)
Leflunomide 10mg tablets (Sigma Pharmaceuticals Plc)
Leflunomide 10mg tablets (Tillomed Laboratories Ltd)
Leflunomide 10mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Leflunomide 10mg tablets 100 tablet
Leflunomide 10mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback